US Stock MarketDetailed Quotes
MDNAF Medicenna Therapeutics
- 1.720
- +0.060+3.61%
15min DelayClose Oct 15 15:41 ET
131.46MMarket Cap-6254P/E (TTM)
1.737High1.635Low84.82KVolume1.650Open1.660Pre Close143.94KTurnover0.38%Turnover RatioLossP/E (Static)76.43MShares2.20052wk High7.93P/B38.52MFloat Cap0.15152wk Low--Dividend TTM22.40MShs Float6.840Historical High--Div YieldTTM6.15%Amplitude0.151Historical Low1.696Avg Price1Lot Size
Medicenna Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -9.40%4.04M | 14.54%18.67M | 34.67%4M | -2.93%4.78M | 33.23%5.44M | 2.98%4.46M | -27.46%16.3M | -4.99%2.97M | 0.49%4.92M | -50.43%4.08M |
| Selling and administrative expenses | -23.88%1.25M | 12.51%7.87M | 54.12%2.13M | -9.63%1.78M | 34.07%2.3M | -14.23%1.65M | -9.40%6.99M | -28.25%1.38M | -0.30%1.97M | -12.13%1.72M |
| -General and administrative expense | -23.88%1.25M | 12.51%7.87M | 54.12%2.13M | -9.63%1.78M | 34.07%2.3M | -14.23%1.65M | -9.40%6.99M | -28.25%1.38M | -0.30%1.97M | -12.13%1.72M |
| Research and development costs | -1.07%2.78M | 16.08%10.8M | 17.47%1.86M | 1.56%2.99M | 32.68%3.13M | 16.63%2.81M | -36.78%9.3M | 33.17%1.59M | 1.31%2.95M | -62.32%2.36M |
| Depreciation amortization depletion | 400.00%5K | 0.00%5K | ---- | 0.00%2K | -50.00%1K | --1K | -86.49%5K | -85.71%1K | -80.00%2K | -80.00%2K |
| -Depreciation and amortization | 400.00%5K | 0.00%5K | ---- | 0.00%2K | -50.00%1K | --1K | -86.49%5K | -85.71%1K | -80.00%2K | -80.00%2K |
| Operating profit | 9.40%-4.04M | -14.54%-18.67M | -34.67%-4M | 2.93%-4.78M | -33.23%-5.44M | -2.98%-4.46M | 27.46%-16.3M | 4.99%-2.97M | -0.49%-4.92M | 50.43%-4.08M |
| Net non-operating interest income expense | -4.62%330K | 31.07%1.2M | -40.31%228K | -17.06%282K | 111.11%342K | 1,053.33%346K | 1,224.64%914K | 4,144.44%382K | 2,025.00%340K | 671.43%162K |
| Non-operating interest income | -4.62%330K | 31.07%1.2M | -40.31%228K | -17.06%282K | 111.11%342K | 1,053.33%346K | 1,224.64%914K | 4,144.44%382K | 2,025.00%340K | 671.43%162K |
| Other net income (expense) | -94.16%73K | -249.60%-7.99M | -699.61%-10.13M | -114.01%-482K | -54.61%1.37M | 762.76%1.25M | 3,187.28%5.34M | -1,339.77%-1.27M | 4,548.65%3.44M | 8,791.18%3.02M |
| Gain on sale of security | -94.16%73K | -249.60%-7.99M | -699.61%-10.13M | -114.01%-482K | -54.61%1.37M | 762.76%1.25M | 3,187.28%5.34M | -1,339.77%-1.27M | 4,548.65%3.44M | 8,791.18%3.02M |
| Income before tax | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M | 89.04%-896K |
| Income tax | ||||||||||
| Net income | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M | 89.04%-896K |
| Net income continuous Operations | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M | 89.04%-896K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M | 89.04%-896K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M | 89.04%-896K |
| Basic earnings per share | -25.00%-0.05 | -131.25%-0.37 | -233.33%-0.2 | -250.00%-0.07 | -400.00%-0.05 | 42.86%-0.04 | 61.90%-0.16 | 0.00%-0.06 | 77.78%-0.02 | 93.33%-0.01 |
| Diluted earnings per share | -25.00%-0.05 | -131.25%-0.37 | -233.33%-0.2 | -250.00%-0.07 | -400.00%-0.05 | 42.86%-0.04 | 61.90%-0.16 | 0.00%-0.06 | 77.78%-0.02 | 93.33%-0.01 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data